Results
heart failure, deaths, cancer, T2DM
KIDNEY DISEASE, CANCER, LIVER DISEASE, HEART FAILURE, CEREBROVASCULAR DISEASE
A total of 399 784 patients with T2DM were eventually enrolled, with 68 318 deaths over a median follow‐up of 6.93 years. The final prediction model included age, sex, heart failure, cerebrovascular disease, moderate or severe kidney disease, moderate or severe liver disease, cancer, insulin use, glycosylated hemoglobin, and high‐density lipoprotein cholesterol. The model showed good discrimination and calibration in the validation sets: the mean C‐index value was 0.8113 (range 0.8110–0.8115) and the predicted risks closely matched the observed risks in the calibration plots.